Work

The British Pharmacopoeia (BP) Draft guidance on replication competent virus assays (from Catapult's regulatory round-up for December 2024)

Year: 2025

Type: other

Abstract: The BP has prepared draft best practice guidance on replication competent virus assays. This guidance is intended to ensure product quality is upheld throughout the product’s lifecycle. The deadline for comments is 28th February 2025. The consultation document and response form can be downloaded here. Published on the 9th of January 2025. Read the entire Regulatory Round-up – December 2024.

Source: Industrias Culturais (Universidade de Coimbra)

DOI: 10.58079/13axw

Author: Adelage

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6955372445

Cites:

Cited by:

Related to: